205 related articles for article (PubMed ID: 34416224)
21. [Effects of tyrosine kinase receptor B and brain-derived neurotrophic factor on chemoresistance in neuroblastoma].
Li AM; Zhang JH; Zhang JH; Zhang KR; Rong DJ
Zhonghua Er Ke Za Zhi; 2006 Jul; 44(7):535-9. PubMed ID: 17044982
[TBL] [Abstract][Full Text] [Related]
22. The neurotrophin receptor TrkB cooperates with c-Met in enhancing neuroblastoma invasiveness.
Hecht M; Schulte JH; Eggert A; Wilting J; Schweigerer L
Carcinogenesis; 2005 Dec; 26(12):2105-15. PubMed ID: 16051641
[TBL] [Abstract][Full Text] [Related]
23. The connections between neural crest development and neuroblastoma.
Jiang M; Stanke J; Lahti JM
Curr Top Dev Biol; 2011; 94():77-127. PubMed ID: 21295685
[TBL] [Abstract][Full Text] [Related]
24. Brain-derived neurotrophic factor (BDNF)-induced tropomyosin-related kinase B (Trk B) signaling is a potential therapeutic target for peritoneal carcinomatosis arising from colorectal cancer.
Tanaka K; Okugawa Y; Toiyama Y; Inoue Y; Saigusa S; Kawamura M; Araki T; Uchida K; Mohri Y; Kusunoki M
PLoS One; 2014; 9(5):e96410. PubMed ID: 24801982
[TBL] [Abstract][Full Text] [Related]
25. Neural crest-derived tumor neuroblastoma and melanoma share 1p13.2 as susceptibility locus that shows a long-range interaction with the SLC16A1 gene.
Avitabile M; Succoio M; Testori A; Cardinale A; Vaksman Z; Lasorsa VA; Cantalupo S; Esposito M; Cimmino F; Montella A; Formicola D; Koster J; Andreotti V; Ghiorzo P; Romano MF; Staibano S; Scalvenzi M; Ayala F; Hakonarson H; Corrias MV; Devoto M; Law MH; Iles MM; Brown K; Diskin S; Zambrano N; Iolascon A; Capasso M
Carcinogenesis; 2020 May; 41(3):284-295. PubMed ID: 31605138
[TBL] [Abstract][Full Text] [Related]
26. Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells.
Matsumoto K; Wada RK; Yamashiro JM; Kaplan DR; Thiele CJ
Cancer Res; 1995 Apr; 55(8):1798-806. PubMed ID: 7712490
[TBL] [Abstract][Full Text] [Related]
27. Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2.
Li D; Mei H; Pu J; Xiang X; Zhao X; Qu H; Huang K; Zheng L; Tong Q
Mol Cancer; 2015 Feb; 14():47. PubMed ID: 25889839
[TBL] [Abstract][Full Text] [Related]
28. TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma.
Kupferman ME; Jiffar T; El-Naggar A; Yilmaz T; Zhou G; Xie T; Feng L; Wang J; Holsinger FC; Yu D; Myers JN
Oncogene; 2010 Apr; 29(14):2047-59. PubMed ID: 20101235
[TBL] [Abstract][Full Text] [Related]
29. Enteric neural crest differentiation in ganglioneuromas implicates Hedgehog signaling in peripheral neuroblastic tumor pathogenesis.
Gershon TR; Shiraz A; Qin LX; Gerald WL; Kenney AM; Cheung NK
PLoS One; 2009 Oct; 4(10):e7491. PubMed ID: 19834598
[TBL] [Abstract][Full Text] [Related]
30. Neuroblastoma pathogenesis: deregulation of embryonic neural crest development.
Tomolonis JA; Agarwal S; Shohet JM
Cell Tissue Res; 2018 May; 372(2):245-262. PubMed ID: 29222693
[TBL] [Abstract][Full Text] [Related]
31. Cooperation of tyrosine kinase receptor TrkB and epidermal growth factor receptor signaling enhances migration and dispersal of lung tumor cells.
Götz R; Sendtner M
PLoS One; 2014; 9(6):e100944. PubMed ID: 24959744
[TBL] [Abstract][Full Text] [Related]
32. The neural crest and cancer: a developmental spin on melanoma.
Kulesa PM; Morrison JA; Bailey CM
Cells Tissues Organs; 2013; 198(1):12-21. PubMed ID: 23774755
[TBL] [Abstract][Full Text] [Related]
33. Loss of neural crest-associated gene FOXD1 impairs melanoma invasion and migration via RAC1B downregulation.
Wu H; Larribère L; Sun Q; Novak D; Sachindra S; Granados K; Umansky V; Utikal J
Int J Cancer; 2018 Dec; 143(11):2962-2972. PubMed ID: 30110134
[TBL] [Abstract][Full Text] [Related]
34. GZD2202, a novel TrkB inhibitor, suppresses BDNF-mediated proliferation and metastasis in neuroblastoma models.
Zou J; Zhang Z; Xu F; Cui S; Qi C; Luo J; Wang Z; Lu X; Tu Z; Ren X; Song L; Ding K
J Drug Target; 2019 Apr; 27(4):442-450. PubMed ID: 30301369
[TBL] [Abstract][Full Text] [Related]
35. Comparison of tyrosine kinase domain properties for the neurotrophin receptors TrkA and TrkB.
Artim SC; Kiyatkin A; Lemmon MA
Biochem J; 2020 Oct; 477(20):4053-4070. PubMed ID: 33043964
[TBL] [Abstract][Full Text] [Related]
36. Restricted response of mesencephalic neural crest to sympathetic differentiation signals in the trunk.
Lee VM; Bronner-Fraser M; Baker CV
Dev Biol; 2005 Feb; 278(1):175-92. PubMed ID: 15649470
[TBL] [Abstract][Full Text] [Related]
37. Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance.
Czarnecka M; Trinh E; Lu C; Kuan-Celarier A; Galli S; Hong SH; Tilan JU; Talisman N; Izycka-Swieszewska E; Tsuei J; Yang C; Martin S; Horton M; Christian D; Everhart L; Maheswaran I; Kitlinska J
Oncogene; 2015 Jun; 34(24):3131-43. PubMed ID: 25132261
[TBL] [Abstract][Full Text] [Related]
38. Neural crest cells development and neuroblastoma progression: Role of Wnt signaling.
Ahmad MH; Ghosh B; Rizvi MA; Ali M; Kaur L; Mondal AC
J Cell Physiol; 2023 Feb; 238(2):306-328. PubMed ID: 36502519
[TBL] [Abstract][Full Text] [Related]
39. Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3'-kinase pathway.
Jaboin J; Kim CJ; Kaplan DR; Thiele CJ
Cancer Res; 2002 Nov; 62(22):6756-63. PubMed ID: 12438277
[TBL] [Abstract][Full Text] [Related]
40. Signal transduction pathways through TRK-A and TRK-B receptors in human neuroblastoma cells.
Sugimoto T; Kuroda H; Horii Y; Moritake H; Tanaka T; Hattori S
Jpn J Cancer Res; 2001 Feb; 92(2):152-60. PubMed ID: 11223544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]